Our story began in 2001 when an inquisitive cardiologist by the name of Dr. Arash Bereliani set out to discover how we can live to be 100 without dying from heart disease. Today, we are privileged to see how the discoveries he made will allow us to celebrate many 100th birthdays. Over the last decade, the B100 method has been successfully in private practice to identify and stratify near-term and intermediate risk of developing cardiovascular disease (CVD) related events, e.g. heart attack or stroke in cardiology patients and, in so doing, prevent heart disease related deaths. As a result, not one patient who has followed the B100 method has died from heart disease. By forming B100, LLC in 2019, the Company has created and developed an innovative approach to bring what was once only available to the most elite high-net-worth, private-practice cardiology patients directly to the consumer at an affordable price through a four-phase risk stratification model. B100 is named after the inspiration that we should all live to Be 100!
Our Company mission is to lead the 21st century through the prevention of heart disease – one heart at a time.